88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

Piramal Pharma Solutions Announces Partnership with Botanix to Support Drug Substance Development Piramal Pharma Solutions has entered into an agreement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, to support the development and commercial supply of Sofdra®. Sofdra ... 2026-05-18T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
MS Pharma Announces Strategic Growth Investment from Olayan Financing Company Strategic Partnership to Accelerate Growth in Saudi Arabia and Across the MENA Region ... 2026-05-18T Banking/Financial Service Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Earendil Labs Announces First Cohort Dosed in Phase I Study of Novel Biparatopic Antibody Targeting Thymic Stromal Lymphopoietin (TSLP) WILMINGTON, Del. , May 18, 2026 /PRNewswire/ -- Earendil Labs, a global leader in AI-driven research and development of next-generation biologics therapeutics, today announced the successful completion ... 2026-05-18T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Lundbeck receives orphan drug designation in Japan for asedebart for the treatment of patients with congenital adrenal hyperplasia and Cushing's disease Congenital adrenal hyperplasia (CAH) and Cushing's disease (CD) are rare disorders characterized by excess adrenocorticotropic hormone (ACTH) produced in the brain 1,2 Current treatments are limited ... 2026-05-18T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Harbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate Hu-mAtrIx™-Enabled Next-Generation ACVR2A/2B- Targeting Antibody Demonstrates Potential to Become a Best-in-Class ... 2026-05-18T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
WuXi AppTec Recognized as a Top-Performing Company on 2026 Dow Jones Best-in-Class World Index SHANGHAI , May 18, 2026 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), has been selected for the 2026 Dow Jones Best-in-Class ... 2026-05-18T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
LOTTE Biologics Expands Antibody Manufacturing Agreement with Ottimo Pharma SEOUL, South Korea , May 18, 2026 /PRNewswire/ -- LOTTE Biologics (Co-CEOs James Park and Yooyeol Shin) announce an expansion of its collaboration with Ottimo Pharma, an innovative biotech company developing ... 2026-05-18T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Atisama Therapeutics Advances RB042 into Multiple Ascending Dose cohorts of Phase 1 Trial and Appoints Bernard Coulie as Chair of the Board RB042 Phase 1 trial advances into multiple ascending dose study cohorts, demonstrating safety and tolerability to date . Dr. Coulie brings more than 25 years of international biopharma leadership ... 2026-05-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Racura Oncology Announces Positive Safety Review Committee Recommendation in ongoing CPACS Clinical Trial Safety Review Committee (SRC) gives Racura Oncology a recommendation to continue the Cardioprotection and Anticancer Synergy (CPACS) study in advanced solid tumor patients ... 2026-05-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Phase II Data from a Randomized Double-Blind Trial of Ligufalimab (Anti-CD47) Combination Therapy in Frontline AML Published at EHA 2026 HONG KONG , May 15, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that compelling results from its randomized, double-blind, placebo-controlled ... 2026-05-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved